Pugliese, G.; Nitro, L.; Allevi, F.; Biglioli, F.; Coccapani, M.; Felisati, G.; Ferella, F.; Ghilardi, G.; Montavoci, L.; Caretti, A.;
et al. Can Serum and Saliva Inflammatory Cytokines Be Considered a Reliable Marker in Chronic Oral Graft-Versus-Host Disease Patients? J. Pers. Med. 2024, 14, 1122.
https://doi.org/10.3390/jpm14121122
AMA Style
Pugliese G, Nitro L, Allevi F, Biglioli F, Coccapani M, Felisati G, Ferella F, Ghilardi G, Montavoci L, Caretti A,
et al. Can Serum and Saliva Inflammatory Cytokines Be Considered a Reliable Marker in Chronic Oral Graft-Versus-Host Disease Patients? Journal of Personalized Medicine. 2024; 14(12):1122.
https://doi.org/10.3390/jpm14121122
Chicago/Turabian Style
Pugliese, Giorgia, Letizia Nitro, Fabiana Allevi, Federico Biglioli, Matilde Coccapani, Giovanni Felisati, Francesco Ferella, Giorgio Ghilardi, Linda Montavoci, Anna Caretti,
and et al. 2024. "Can Serum and Saliva Inflammatory Cytokines Be Considered a Reliable Marker in Chronic Oral Graft-Versus-Host Disease Patients?" Journal of Personalized Medicine 14, no. 12: 1122.
https://doi.org/10.3390/jpm14121122
APA Style
Pugliese, G., Nitro, L., Allevi, F., Biglioli, F., Coccapani, M., Felisati, G., Ferella, F., Ghilardi, G., Montavoci, L., Caretti, A., & Saibene, A. M.
(2024). Can Serum and Saliva Inflammatory Cytokines Be Considered a Reliable Marker in Chronic Oral Graft-Versus-Host Disease Patients? Journal of Personalized Medicine, 14(12), 1122.
https://doi.org/10.3390/jpm14121122